NYSE$UNH

UnitedHealth · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

UnitedHealth Group reported Q1 2025 revenue of $109.6B with net earnings of $6.5B and diluted EPS of $6.85.

Total revenues were $109.6 billion for the quarter ended March 31, 2025, up about 10% year over year, as Optum Rx and UnitedHealthcare grew despite prior-year cyberattack impacts. Net earnings were $6.5 billion ($6.85 diluted EPS) versus a loss a year ago when Change Healthcare disruption weighed on results. Medical cost trends, Medicare Advantage funding, and Optum services mix remain central to the outlook.

  • Q1 revenue $109.6B (+10% YoY); UnitedHealthcare and Optum drove growth.
  • Net earnings $6.5B; diluted EPS $6.85 versus $(1.53) a year ago.
  • Optum Rx and health services benefited from cyber recovery.
  • Medicare Advantage utilization and regulatory rates remain key sensitivities.

Headline financials

Total Revenue

$110B

Previous: $99.8B+9.8%
EPS (adj)

$6.85

Previous: -$1.53+547.7%
Capital Expenditures

-$898M

Previous: -$743M-20.9%
Free Cash Flow

$4.56B

Previous: -$2.15B+311.8%
Net Income

$6.47B

Previous: -$1.41B+559.5%
Operating Income

$9.12B

Previous: $7.93B+15.0%

Revenue & EPS history

UnitedHealth · Revenue · Quarterly

$110B

Q1 2025+9.8%vs Q1 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

UnitedHealth · $92.4B total across 4 segments · Q3 2023

  • Premiums
    $72.3B+12.2%
  • Products
    $10.4B+12.7%
  • Services
    $8.67B+29.4%
  • Investment & Other
    $997M+94.3%

Forward guidance

The quarterly filing discusses operating priorities, liquidity, and sector risks.

Tailwinds

  • MD&A outlines strategic priorities and capital allocation.
  • Segment commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.9%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+2.6%

Avg return

30 days after

63%

46 / 73 earnings

Positive

+11.2%

Q2 2024

Best reaction

-22.4%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+9.7%+18.1%
Q4 2025-11.2%-18.4%-18.5%
Q3 2025+0.1%-6.7%-9.9%
Q2 2025+0.6%+21.2%+38.2%
Q1 2025-22.4%-27.0%-50.1%
Q4 2024-6.2%-3.4%-3.7%
Q3 2024-5.6%-5.9%-2.0%
Q2 2024+11.2%+9.7%+12.5%
Q1 2024+7.5%+12.5%+17.0%
Q4 2023-3.8%-2.7%-4.0%
Q3 2023+2.4%+2.0%+3.0%
Q2 2023+8.1%+12.5%+13.5%
Q1 2023-4.0%-7.6%-6.7%
Q4 2022-2.1%-3.9%-0.3%
Q3 2022+2.3%+2.0%+2.4%
Q2 2022+3.4%+3.4%+8.2%
Q1 2022-0.5%+0.1%-9.6%
Q4 2021+0.4%+0.3%+1.5%
Q3 2021+6.1%+5.2%+13.7%
Q2 2021+1.2%-0.4%-1.2%
Q1 2021+4.1%+5.6%+9.1%
Q4 2020+0.8%-1.2%-7.8%
Q3 2020-2.1%-2.2%+7.3%
Q2 2020-0.4%-1.6%+4.9%
Q1 2020+10.3%+4.3%+7.6%
Q4 2019+4.3%+3.5%+3.7%
Q3 2019+7.4%+11.2%+16.0%
Q2 2019-3.8%-4.4%-7.9%
Q1 2019-5.8%-3.7%+2.9%
Q4 2018+5.4%+7.0%+7.0%
Q3 2018+2.7%+1.9%+1.8%
Q2 2018-0.6%-1.7%+2.4%
Q1 2018+2.6%+2.1%+5.5%
Q4 2017+4.3%+6.4%-1.1%
Q3 2017+6.2%+7.4%+9.3%
Q2 2017+1.5%+2.9%+3.4%
Q1 2017+1.2%+2.4%+2.6%
Q4 2016-2.5%-1.9%+1.1%
Q3 2016+7.6%+8.4%+12.4%
Q2 2016+1.6%+2.1%+1.0%
Q1 2016+4.8%
Q4 2015+5.1%
Q3 2015-1.7%
Q2 2015-1.6%
Q1 2015+1.2%
Q4 2014+7.8%
Q3 2014+7.3%
Q2 2014+2.1%
Q1 2014-4.1%
Q4 2013-3.1%
Q3 2013-8.6%
Q2 2013+7.9%
Q1 2013-3.2%
Q4 2012+1.7%
Q3 2012-2.6%
Q2 2012-1.7%
Q1 2012+3.8%
Q4 2011+2.3%
Q3 2011-2.2%
Q2 2011-1.7%
Q1 2011+0.5%
Q4 2010+0.7%
Q3 2010-0.5%
Q2 2010+1.6%
Q1 2009-0.8%
Q1 2010-0.2%
Q4 2009+0.4%
Q4 2007+0.4%
Q3 2008+5.5%
Q3 2009+5.5%
Q4 2008+1.3%
Q2 2008+1.3%
Q2 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro